KBC Group’s Exelixis EXEL Stock Holding History
Bought
Maintained
Sold
Other funds holding EXEL
FCM
VPM
VCM
KBC Group's EXEL Position: Q1 2026 in Review
KBC Group increased its Exelixis (EXEL) stake by 2.8% in Q1 2026, buying an estimated $53.1K and bringing the position to 45,472 shares worth $1.95M. The position accounts for ﹤0.01% of the portfolio, ranked #656.
KBC Group first reported a position in EXEL in Q4 2016 and has held it in 22 quarters since. The position peaked at $27.7M in Q2 2017. 694 funds tracked by Wall St. Rank hold EXEL as of Q1 2026.
- KBC Group held 45,472 shares of Exelixis worth $1.95M as of Q1 2026.
- KBC Group bought 1,236 Exelixis shares in Q1 2026, an estimated $53.1K.
- Exelixis made up ﹤0.01% of KBC Group's portfolio in Q1 2026, its #656 holding.
- KBC Group first reported a position in Exelixis in Q4 2016 and has held it in 22 quarters since.
- KBC Group's Exelixis position peaked at $27.7M in Q2 2017.
- 694 funds tracked by Wall St. Rank held Exelixis as of Q1 2026.
Based on KBC Group's 13F filing for Q1 2026, filed 7 May 2026.